Cargando…
The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study
Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 (NRF2) protein is the master regulator of oxidative stress, which is at the basis of various chronic diseases including cancer. Hyperactivation of NRF2 in already established cancers can promote cell proliferation and resistance to therapies, s...
Autores principales: | Garufi, Alessia, Pistritto, Giuseppa, D’Orazi, Valerio, Cirone, Mara, D’Orazi, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946796/ https://www.ncbi.nlm.nih.gov/pubmed/35327653 http://dx.doi.org/10.3390/biom12030461 |
Ejemplares similares
-
Reactivation of mutant p53 by capsaicin, the major constituent of peppers
por: Garufi, Alessia, et al.
Publicado: (2016) -
The Sweet Side of HIPK2
por: Garufi, Alessia, et al.
Publicado: (2023) -
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases
por: Garufi, Alessia, et al.
Publicado: (2023) -
A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status
por: Garufi, Alessia, et al.
Publicado: (2020) -
Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response
por: Garufi, Alessia, et al.
Publicado: (2019)